April 19th 2024
Results published in the journal Ophthalmology find no risk reduction from daily one-gram capsules of omega-3 fatty acids.
Eyelea is Shown to Be More Effective Than Avastin at Weaning nvAMD Patients off Treatments
December 8th 2022The early response to neovascular age-related macular degeneration (nvAMD) treatment with aflibercept (Eyelea) was much greater than the response to bevacizumab (Avastin), in hopes of weaning those affected off the therapies sooner.
Read More
Can Ocular Biomarkers Be Used to Diagnose Alzheimer’s Disease?
December 5th 2022In an umbrella review — a review of reviews — investigators found that so far, studies of ocular biomarkers to diagnose Alzheimer’s disease had important limitations. Longitudinal studies that use artificial intelligence could perhaps identify ocular biomarkers, the researchers suggest.
Read More